Abstract
Objective
The aim of this study was to explore the effects on malignant proliferation of A549 cell by silencing cyclooxygenase (COX)-2.
Methods
In the present study, we constructed three siRNA vectors producing small interference RNA. The siRNA vectors and the vacant vectors were transfected into A549 cell with lipofectamine respectively and the transfected cell strains were constructed. The change of COX-2 expression levels was examined by Western blot and RT-PCR. The effects on the proliferation of lung cancer cells were studied by cell growth curve, clonogenic assay and xenograft assays.
Results
The siRNA expression vectors produced marked effects in A549 cell but the inhibited effects were different. The effect of psi-10 was best and the mRNA and protein levels of COX-2 reduced 61.2% and 56.2% respectively in A549-si10 cell in contrast to the control. The growth of A549 cell slowed and the colony formation rate reduced after silencing COX-2. In xenograft assays, the growth speeds of tumor became slow and the numbers of tumor reduced after silencing COX-2.
Conclusion
The si10 target of COX-2 has the best silencing effect in A549 cell and the best inhibition effect on malignant proliferation of A549 cell in vivo and in vitro.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Smith WL, Langenbach R. Why are there two cyclooxygenase enzymes? J Clin Invest, 2001, 107: 1491–1495.
Brown JR, DuBois RN. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol, 2005, 23: 2840–2855.
Denkert C, Kobel M, Berger S, et al. Expression of cyclooxygenase-2 in human malignant melanoma. Cancer Res, 2001, 61: 303–308.
Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res, 2000, 60: 1306–1311.
Kulkarni S, Rader JS, Zhang F, et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res, 2001, 7: 429–434.
Kokawa A, Kondo H, Gotoda T, et al. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer, 2001, 91: 333–338.
Eberhart CE, Coffey RJ, Radhika A, et al. Upregulation of cyclooxygenase-2 gene in human colorectal adenomas and adenocarcinomas. Gastroenterology, 1994, 107: 1183–1188
Gupta S, Srivastava M, Ahmad N, et al. Over expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate, 2000, 42:73–78.
Kulkarni S, Rader JS, Zhang F, et al. Cyclooxygenase-2 is over expressed in human cervical cancer. Clin Cancer Res, 2001, 7: 429–434.
Sahin M, Sahin E, Gümüslü S. Cyclooxygenase-2 in cancer and angiogenesis. Angiology, 2009, 60: 242–253.
Fidler MJ, Argiris A, Patel JD, et al. The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib. Clin Cancer Res, 2008, 14: 2088–2094.
Van Dyke AL, Cote ML, Prysak GM, et al. COX-2/EGFR expression and survival among women with adenocarcinoma of the lung. Carcinogenesis, 2008, 29: 1781–1787.
Denkert C, Kobel M, Berger S, et al. Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res, 2001, 61: 303–308.
Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res, 2000, 60: 1306–1311.
Banu N, Buda A, Chell S, et al. Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy. Cell Prolif, 2007, 40: 768–779.
Leahy KM, Ornberg RL, Wang Y, et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res, 2002, 62: 625–631.
Jang MC, Liao CF, Lee PH. Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production and inhibits in vitro invasion of tumor cells. Biochem Biophys Res Commun, 2001, 282: 671–677.
Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 1998, 93: 705–716.
Wolff H, Saukkonen K, Anttila S, et al. Expression of cyclooxygenase-2 in human lung cancer. Cancer Res, 1998, 58: 4997–5001.
Dohadwala M, Luo J, Zhu Li, et al. Non-small cell lung cancer cyclooxygenase-2-dependent invasion in mediated by CD44. J Biol Chem, 2001, 276: 20809–20812.
Hosomi Y, Yokose T, Hirose Y, et al. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer, 2000, 30: 73–81.
Kokawa A, Kondo H, Gotoda T, et al. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer, 2001, 91: 333–338.
Li G, Yang T, Yan J. Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem Biophys Res Commun, 2002, 299: 886–890.
Choe MS, Zhang X, Shin HJC, et al. Interaction between epidermal growth factor receptor and cyclooxygenase 2 mediated pathways and its implications for the chemoprevention of head and neck cancer. Mol Cancer Ther, 2005, 4: 1448–1455.
Charames GS, Bapat B. Cyclooxygenase-2 knockdown by RNA interference in colon cancer. Int J Oncol, 2006, 28: 543–549.
Strillacci A, Griffoni C, Valerii MC, et al. RNAi-based strategies for cyclooxygenase-2 inhibition in cancer. J Biomed Biotechnol, 2010, Epub 2010 Jun 13.
Chan MW, Wong CY, Cheng AS, et al. Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells. Oncol Rep, 2007, 18: 1557–1562.
Zhao Q, Wang C, Zhu J, et al. Do RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cells: a case control study. J Exp Clin Cancer Res, 2011, 30: 26.
Li WY, Wang H, Lai BT, et al. The effects of the same target on malignant proliferation of human lung cancer cells with different expression levels of COX-2 protein. Chinese-German J Clin Oncol, 2010, 9: 125–132.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, W., Yue, W., Zhang, L. et al. COX-2 silencing inhibits cell proliferation in A549 cell. Chin. -Ger. J. Clin. Oncol. 10, 423–427 (2011). https://doi.org/10.1007/s10330-011-0829-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-011-0829-0